Professor Jean - Charles Soria,
Chairman of the Drug Development
Department at Gustave Roussy Cancer campus, France, will tell the Symposium: «
Currently, there are no approved targeted therapies for mutant EGFR lung cancer patients who develop the T790M mutation, which means their disease inevitably will get worse.
Mr. Wardropper,
currently Iris and B. Gerald Cantor
Chairman,
Department of European Sculpture and Decorative Arts, The Metropolitan Museum
of Art, will take up the post as
of October 3, 2011, with the retirement
of the Frick's Director
of eight years, Anne L. Poulet.